Summit Therapeutics Inc. Annual Operating Margin in % from 2017 to 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Summit Therapeutics Inc. quarterly/annual Operating Margin history and growth rate from 2017 to 2022.
  • Summit Therapeutics Inc. Operating Margin for the quarter ending June 30, 2023 was -268K %, a 6725% decline year-over-year.
  • Summit Therapeutics Inc. annual Operating Margin for 2022 was -10.2K %, a 115% decline from 2021.
  • Summit Therapeutics Inc. annual Operating Margin for 2021 was -4.76K %, a 23% increase from 2020.
  • Summit Therapeutics Inc. annual Operating Margin for 2020 was -6.19K %, a 67.3% decline from 2019.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -10.2K -5.46K -115% Jan 1, 2022 Dec 31, 2022
2021 -4.76K +1.42K +23% Jan 1, 2021 Dec 31, 2021
2020 -6.19K -2.49K -67.3% Jan 1, 2020 Dec 31, 2020
2019 -3.7K -3.71K -39270% Feb 1, 2019 Dec 31, 2019
2018 9.44 +186 Feb 1, 2018 Jan 31, 2019
2017 -176 Feb 1, 2017 Jan 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.